Can venlafaxine extended-release cause bruxism (teeth grinding)?

Yes, venlafaxine extended-release can cause bruxism (teeth grinding).

Bruxism is a recognized adverse effect of venlafaxine and other serotonin-norepinephrine reuptake inhibitors (SNRIs), though it is not listed in the FDA drug label's common side effects. While the official FDA labeling for venlafaxine does not specifically mention bruxism 1, multiple research studies and pharmacovigilance data confirm this association.

Evidence for Venlafaxine-Induced Bruxism

The strongest evidence comes from:

• WHO pharmacovigilance database analysis showing venlafaxine as the third most commonly reported antidepressant associated with bruxism (after sertraline and escitalopram), with a significant reporting odds ratio 2

• Systematic review of case reports identifying venlafaxine as one of the three most commonly reported offending agents for antidepressant-associated bruxism 3

• Large observational study (807 patients) finding venlafaxine among the antidepressants most associated with bruxism, with an overall incidence of antidepressant-induced bruxism of 14.0% 4

• Individual case reports documenting severe bruxism developing within 2 weeks of venlafaxine initiation, with resolution 2 months after discontinuation 5, 6

Clinical Characteristics

Onset and timing:

• Symptoms typically begin within 3-4 weeks of medication initiation 3
• Can occur with both short-term and long-term use 3
• May develop even at therapeutic doses

Patient demographics:

• More commonly reported in female patients 3, 4
• Can occur in both pediatric and adult populations 3

Mechanism

The mechanism appears related to norepinephrine reuptake inhibition more than serotonin reuptake inhibition. Pharmacovigilance data showed a negative association between bruxism reporting and NET (norepinephrine transporter) pKi values, suggesting this adverse effect is more closely linked to norepinephrine than serotonin effects 2. This explains why SNRIs like venlafaxine are particularly implicated.

Management Options

If bruxism develops on venlafaxine, consider these approaches in order:

1. Add buspirone 5-10 mg/day

   • Most evidence-supported intervention
   • Resolution typically within 3-4 weeks 3, 7
   • Mechanism: dopaminergic modulation may counteract serotonergic-dopaminergic imbalance

2. Dose reduction of venlafaxine

   • May reduce severity while maintaining antidepressant efficacy 3

3. Switch to alternative antidepressant

   • Consider agents with less noradrenergic activity
   • Symptoms typically resolve within 3-4 weeks of discontinuation 3, 5

4. Adjunctive gabapentin

   • Case report evidence for complete resolution 6
   • May be particularly useful if buspirone ineffective

Important Caveats

• Bruxism is underrecognized among prescribers but well-documented in dental literature 3

• The FDA drug label lists "tremor" as a known adverse effect 1, which may represent a related movement disorder phenomenon

• Screen for bruxism symptoms during early titration, especially in patients with:

  • Family history of teeth grinding 8
  • Female sex 3, 4
  • Poor sleep quality 8

• Bruxism can lead to significant morbidity: jaw pain, tooth wear, temporomandibular joint dysfunction, and impaired quality of life 7

Do not dismiss patient reports of jaw clenching or teeth grinding as unrelated to medication—the temporal relationship and resolution with intervention strongly support causality in most cases (Naranjo scores typically 7-9, indicating "probable" causation) 7.